0.181 USD
0 (0%)
0.154 USD
-0.03 (-14.92%)
ChartMill assigns a Buy % Consensus number of 83% to GMVD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.08. This target is 2154.14% above the current price.
GMVD was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about GMVD.
In the previous month the buy percentage consensus was at a similar level.
GMVD was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-06-20 | ThinkEquity | Initiate | Buy |
| 2022-01-18 | EF Hutton | Initiate | Buy |
G MEDICAL INNOVATION HOLDING / GMVD FAQ
What do analysts expect the price target to be for G MEDICAL INNOVATION HOLDING (GMVD)?
7 analysts have analysed GMVD and the average price target is 4.08 USD. This implies a price increase of 2154.14% is expected in the next year compared to the current price of 0.181.
What is the consensus rating for G MEDICAL INNOVATION HOLDING (GMVD) stock?
The consensus rating for G MEDICAL INNOVATION HOLDING (GMVD) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for GMVD stock?
The number of analysts covering G MEDICAL INNOVATION HOLDING (GMVD) is 7.